BlueDop Medical’s Post

📄 Our paper reporting on the outcome after Left Ventricular Assist Device (LVAD) exchange has just been published in the European Journal of Cardio-Thoracic Surgery! In short, our study indicates that having a HeartWare Ventricular Assist Device (HVAD) as index device may be associated with a higher risk of developing right heart failure and respiratory failure after device exchange. Furthermore, our results show that the six-year mortality after LVAD exchange is relatively low. However, other post-operative events are common. Many thanks to all co-authors for collaborating on this study: Faiz Ramjankhan, Niels van der Kaaij, Monica Gianoli, Linda van Laake and Mostafa Mokhles MD PhD LL.M. Find out more about our findings through the link below:

🌟 Research #Highlight: Complication Risks in Morbidly Obese Patients Undergoing #TKA Excited to share a pivotal study titled "Risk of #complications with prolonged operative time in morbidly obese patients undergoing elective total knee #arthroplasty" by Raman Mundi, Nicholas Nucci, Jesse Wolfstadt, Daniel Pincus, and Harman Chaudhry. 🔍 Key Findings: ✅ #DVT Risk: Significantly increased risk of deep vein thrombosis (DVT) with operative time exceeding 120 mins (OR 2.47) and 91–120 mins (OR 1.73). ✅ #Infection & PE Risk: No significant association between longer operative time and superficial/deep surgical site infection (#SSI) or pulmonary embolism (PE). 🔗 Diving into these important findings, check out the full article: https://lnkd.in/gr-NnjgG #Orthopedics #KneeArthroplasty #MedicalResearch #TKA #Obesity #Arthroplasty #SurgicalComplications

Inflammatory Bowel Disease (IBD), Crohn’s disease and ulcerative colitis, is a chronic condition affecting many people’s daily lives. The findings of IBD UK’s report, The State of IBD Care in the UK, published this week made for some uncomfortable reading. It showed that flare-ups (a temporary worsening of symptoms after not having any for a period of time) and emergency hospital admissions due to IBD continue to rise. At IBD onset, rapid diagnosis and intervention are essential to prevent worsening of symptoms and long-term complications. But even with symptoms managed through treatment, patients can still experience a relapse, ranging from mild to requiring emergency hospital admission. Although achieving remission is an important goal in managing IBD, therapeutic goals for Crohn’s disease and ulcerative colitis have evolved to include endoscopic healing. Endoscopic healing is increasingly recognised as a predictor of long-term improvement for patients and associated with prolonged clinical remission. I believe regular reviews should be part of the management plan to assess treatment efficacy, disease activity and, importantly, healing of the colon lining. The report highlighted the need to introduce agreed NHS waiting times for IBD endoscopies and surgery. I support this call and the team at Johnson & Johnson will continue our work to progress interventions for patients aimed at long-term health improvement. #FaceTheFacts CP-491686, December 2024

🚨 Stay Alert for Necrotizing Fasciitis 🚨 Necrotizing fasciitis (NF) is a rare but rapidly progressing infection that targets the fascia and subcutaneous tissue. Early recognition and prompt treatment are crucial to improve patient outcomes. Here's a brief overview: 🔍 Risk Factors: - Diabetes mellitus (DM) - Obesity - Immunosuppression - Recent surgeries - Traumatic wounds - IV drug use 🩺 Clinical Signs: - Severe pain disproportionate to physical findings - Erythema without sharp margins - Hemorrhagic bullae - Crepitus in certain infections - Systemic symptoms like fever and tachycardia 🧪 Diagnosis: - Surgical exploration is essential. - Imaging (CT) can help but should not delay surgery. - LRINEC score can aid in risk stratification. 💉 Treatment: - Immediate surgical debridement - Broad-spectrum antibiotics (e.g., piperacillin-tazobactam, clindamycin, vancomycin) Patients diagnosed with NF need urgent care and often multiple surgical interventions. #Healthcare #MedicalEmergency #InfectionControl #SurgicalIntervention #NecrotizingFasciitis #MedicalAwareness #PatientCare

🔴Diagnosis and treatment modalities of osteomyelitis 🔹Osteomyelitis can be acute or chronic. Acute osteomyelitis patients present with symptoms such as pain, fever, and edema in the affected area several days to weeks after identifying the site without bone loss. 🔹After a few months to a few years of infection, chronic osteomyelitis can appear in necrotic bone and fistulous channels connecting the skin to the bone. 🔹In osteomyelitis, the mechanisms are hematogenous or non-hematogenous 🔹Hematogenous osteomyelitis is a disorder in which microbes enter the bones due to blood flow. Insecure people, children and people are more likely to get this disease. 🔹Vertebral osteomyelitis is the most common type of hematogenous osteomyelitis. Certain patients have discomfort in the neck, muscle pain and sometimes fever. 🔹Long, pelvic and sternoclavicular bones are other bones in which hematogenous osteomyelitis occurs. 🔹Immature children suffering from hematogenous osteomyelitis develop it in the metaphysis of long bones close to the plates, while bones and bones are especially sensitive. 🔹Non-hematogenous osteomyelitis is caused by direct inoculation during surgery, after trauma, or as a result of diffusion in the soft tissues and adjacent joints. 🔴 The following case was captured through various imaging techniques and thus represents an ideal case of chronic osteomyelitis.👇🏻

#pancreas #inflammation #surgery  #medicine #medicalsciences #healthcare https://lnkd.in/eqaYFN3U Importance Gallstone pancreatitis (GSP) is the leading cause of acute #pancreatitis, accounting for approximately 50% of cases. Without appropriate and timely treatment, patients are at increased risk of disease progression and recurrence. While there is increasing consensus among guidelines for the management of mild GSP, adherence to these #guidelines remains poor. In addition, there is minimal evidence to guide clinicians in the treatment of moderately severe and severe pancreatitis.

Check out this latest study on the use of continuous pressure monitoring! The study utilized our MEMS-based pressure monitoring device, which was inserted into the muscle belly of a pediatric patient who presented with severe pain after surgery following recurrent patellar dislocation. Read the article to find out how the trend aided in the clinical diagnosis of this case: https://lnkd.in/ewHXEbA6 #surgery #orthopedics #patientcare Ed Harvey

Epi+Gen CHD™: A Proactive Solution for Assessing Heart Disease Risk Epi+Gen CHD™ is a prescription-only blood test designed to help healthcare providers assess their patient's risk for a coronary heart disease (CHD) event, including heart attacks. Epi+Gen CHD is intended for patients who: ▪ Are between the ages of 35-75 years old ▪ Have not been diagnosed with CHD ▪ Have not experienced a heart attack, undergone cardiac surgery, or had an abnormal stress test ▪ Are not experiencing angina (chest pain), particularly with exertion ▪ Have not undergone a bone marrow transplant Rooted in the science of epigenetics, Epi+Gen CHD provides personalized insights into the patient's molecular drivers of risk. Encourage your patients to take a proactive approach to their heart health. Consider Epi+Gen CHD™ as part of their overall risk management strategy. Access our: https://cdio.ai/resources/

A total of 4917 patients were included in the analysis, 3909 (79.5%) patients without and 1008 (20.5%) patients with preoperative septic cerebral embolism. Patients with preoperative septic cerebral embolism had more baseline comorbidities. Mitral valve endocarditis (44.1% vs. 33.0% p < 0.001), large vegetations >10mm (43.1% vs. 30.0%,p<0.001), and Staphylococcus species infection (42.3% vs. 21.3%, p < 0.001) were more frequent in the cerebral embolism group. Among patients with preoperative cerebral embolism, 286 (28.4%) patients had no stroke signs (silent stroke). After matching (1008 matched pairs), there was no statistically significant difference in 30-day mortality (20.1%. vs. 22.8%; p = 0.14) and 5-year survival (47.8% vs. 49.1%; stratified log-rank p = 0.77) in patients with and without preoperative cerebral embolism, respectively. Preoperative septic cerebral embolism in patients with infective endocarditis requiring valve surgery does not negatively affect early or late mortality, therefore, it should not play a major role in deciding if surgery is to be performed.